MoneyWorks4Me

Jubilant Pharmova informs about updates

03 Feb 2024 Evaluate
Jubilant Pharmova has informed about completion of USFDA audit of Solid dosage manufacturing facility at Roorkee plant pursuant to Provisions of Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE. 
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..